Table 1 Baseline characteristics between LLR and SBRT groups before PSM and after PSM.

From: Stereotactic body radiotherapy versus laparoscopic liver resection for single hepatocellular carcinoma ≤ 5 cm: a retrospective, multicenter, cohort study

Characteristics

Before PSM

After PSM

LLR

SBRT

p value

LLR

SBRT

p value

(n = 268)

(n = 115)

(n = 98)

(n = 98)

Age > 60(%)

134(50.0%)

70(60.9%)

0.051

56(57.1%)

59(60.2%)

0.663

Sex, male(%)

221(71.3%)

89(77.4%)

0.247

75(76.5%)

76(77.6%)

0.865

Hypertension(%)

66(24.6%)

47(40.9%)

0.001

32(32.7%)

39(39.8%)

0.298

Diabetes(%)

73(27.2%)

22(19.1%)

0.092

23(23.5%)

21(21.4%)

0.732

HBV infection(%)

221(82.5%)

85(73.9%)

0.056

78(79.6%)

73(74.5%)

0.396

Child-Pugh class

      

A

245(91.4%)

102(88.7%)

0.403

91(92.9%)

90(91.8%)

0.788

B

23(8.6%)

13(11.3%)

 

7(7.1%)

8(8.2%)

 

WBC(×10^9/L)

      

≤ 4

33(12.3%)

49(42.6%)

< 0.001

28(28.6%)

33(33.7%)

0.440

> 4

235(87.7%)

66(57.4%)

 

70(71.4%)

65(66.3%)

 

Platelet count(×10^9/L)

      

≤ 100

42(15.7%)

46(40.0%)

< 0.001

30(30.6%)

33(33.7%)

0.646

> 100

226(84.3%)

69(60.0%)

 

68(69.4%)

65(66.3%)

 

TBIL(µmol/L)

      

≤ 17.1

245(91.4%)

92(80.0%)

0.002

86(87.8%)

83(84.7%)

0.534

> 17.1

23(8.6%)

23(20.0%)

 

12(12.2%)

15(15.3%)

 

ALB (g/L)

      

≤ 35

82(30.6%)

25(21.7%)

0.077

25(25.5%)

22(22.4%)

0.616

> 35

186(69.4%)

90(78.3%)

 

73(74.5%)

76(77.6%)

 

PT (s)

      

≤ 13

249(92.9%)

89(77.4%)

< 0.001

85(86.7%)

86(87.8%)

0.830

> 13

19(7.1%)

26(22.6%)

 

13(13.3%)

12(12.2%)

 

AFP (ng/mL)

      

≤ 400

242(90.3%)

93(80.9%)

0.011

88(89.8%)

86(87.8%)

0.651

> 400

26(9.7%)

22(19.1%)

 

10(10.2%)

12(12.2%)

 

ECOG

      

0

74(27.6%)

32(27.8%)

0.966

33(33.7%)

30(30.6%)

0.646

1–2

194(72.4%)

83(72.2%)

 

65(66.3%)

68(69.4%)

 

Tumor diameter

      

≤ 3

69(25.7%)

30(26.1%)

0.944

30(30.6%)

28(28.6%)

0.754

3–5

199(74.3%)

85(73.9%)

 

68(69.4%)

70(71.4%)

 

Tumor location

      

Perivascular

112(41.8%)

60(52.2%)

0.061

42(42.9%)

51(52.0%)

0.198

Other

156(58.2%)

55(47.8%)

 

56(57.1%)

47(48.0%)

 
  1. PSM, propensity score matching; LLR, laparoscopic liver resection; SBRT, stereotactic body radiation therapy; HBV, hepatitis B virus; ECOG, Eastern Cooperative Oncology Group; AFP, alpha-fetoprotein.